Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > A move all Oncy shareholders need to make, to screw the shor
View:
Post by Peladawn on Apr 29, 2024 10:13am

A move all Oncy shareholders need to make, to screw the shor

SARASOTA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Trump Media & Technology Group Corp. (NASDAQ: DJT) (“TMTG” or the “Company”) is highlighting actions DJT shareholders can take to prevent the lending of their shares by brokerage firms for the purpose of short selling.

The Company’s shareholder base primarily consists of retail investors who hold their shares through various brokerage firms. Many of these retail shareholders invested in DJT because they support TMTG’s mission to create a free-speech beachhead against Big Tech censorship.

TMTG wants to clarify that if shares are currently on loan by brokerage firms to facilitate short selling, shareholders have the option of asking their broker to recall their shares.

 

After recalling their shares, long-term shareholders who believe in the Company’s future can then hold their DJT shares in a cash account, opt out of any securities lending programs, or move their shares to a Direct Registration (“DRS”) account at the Company’s transfer agent, Odyssey Transfer & Trust Company.

Comment by Peladawn on Apr 29, 2024 10:18am
DJT is up over 10% today on this very smart move by retail shareholders!
Comment by CMHarring218431 on Apr 29, 2024 12:29pm
Another simple way to keep your shares from being lent out to shorters is to call your broker and put in an order to sell your shares at like six dollars. Then your shares cannot be borrowed by shorters
Comment by Peladawn on Apr 29, 2024 1:40pm
CMHthats correct for the TSX, but for the Nasdaq its a bit more hassle.by the way, definitely do NOT put your shares up for sale at $6!..If they announce a multi billion dollar buyout, the price will soar FAR above $6, and you will miss out big time!..maybe try $600.
Comment by canadafan on Apr 29, 2024 2:51pm
I think the suggestion for putting shares up for sale without news is potentially a disaster. The right news, which could happen moment, would move the price beyond any number you could guess. Sit back & wait. Lots of catalysts expected soon.
Comment by Peladawn on Apr 29, 2024 4:11pm
Cf.I get what youre saying, but I think youd be safe at $600.at least I know Id be ok with letting my 31k go at $600/ share.lol.
Comment by Buckhenry on Apr 29, 2024 4:36pm
That's roughly $40B or so... yeah baby!!!  Send us some of what your smokin!!
Comment by Buckhenry on Apr 29, 2024 4:47pm
Just for the record... I wished you were even half right at say $300 per share!!
Comment by canadafan on Apr 29, 2024 5:55pm
Assuming a buyout of $5 billion. Which is on record by all analysts as one years income, very possible. $5 billion buyout would be $60/ ps. The upper end? Depends on how things progress within the next few trial updates. Lower end..? They have said many times $1 billion is a minimum staring point. That was long before the recent biotech market place activities. Again acquisition of much less than ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities